Retinopathy risk calculators in the prediction of sight-threatening diabetic retinopathy in type 2 diabetes: A FIELD substudy.
Diabetic retinopathy
Fenofibrate
Risk calculator
Validation study
Journal
Diabetes research and clinical practice
ISSN: 1872-8227
Titre abrégé: Diabetes Res Clin Pract
Pays: Ireland
ID NLM: 8508335
Informations de publication
Date de publication:
Apr 2022
Apr 2022
Historique:
received:
20
11
2021
revised:
08
02
2022
accepted:
16
03
2022
pubmed:
23
3
2022
medline:
6
5
2022
entrez:
22
3
2022
Statut:
ppublish
Résumé
To evaluate the risk algorithm by Aspelund et al. for predicting sight-threatening diabetic retinopathy (STDR) in Type 2 diabetes (T2D), and to develop a new STDR prediction model. The Aspelund et al. algorithm was used to calculate STDR risk from baseline variables in 1012 participants in the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) ophthalmological substudy, compared to on-trial STDR status, and receiver operating characteristic analysis performed. Using multivariable logistic regression, traditional risk factors and fenofibrate allocation as STDR predictors were evaluated, with bootstrap-based optimism-adjusted estimates of predictive performance calculated. STDR developed in 28 participants. The Aspelund et al. algorithm predicted STDR at 2- and 5-years with area under the curve (AUC) 0.86 (95% CI 0.77-0.94) and 0.86 (0.81-0.92), respectively. In the second model STDR risk factors were any DR at baseline (OR 24.0 [95% CI 5.53-104]), HbA1c (OR 1.95 [1.43-2.64]) and male sex (OR 4.34 [1.32-14.3]), while fenofibrate (OR 0.13 [0.05-0.38]) was protective. This model had excellent discriminatory ability (AUC = 0.89). The algorithm by Aspelund et al. predicts STDR well in the FIELD ophthalmology substudy. Logistic regression analysis found DR at baseline, male sex, and HbA1c were predictive of STDR and, fenofibrate was protective.
Identifiants
pubmed: 35314259
pii: S0168-8227(22)00647-7
doi: 10.1016/j.diabres.2022.109835
pii:
doi:
Substances chimiques
Glycated Hemoglobin A
0
Fenofibrate
U202363UOS
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
109835Commentaires et corrections
Type : ErratumIn
Informations de copyright
Copyright © 2022 Elsevier B.V. All rights reserved.